Literature DB >> 33432745

Mental health problems among COVID-19 survivors in Wuhan, China.

Qi Mei1, Fei Wang2, Amy Bryant3, Li Wei2, Xianglin Yuan1, Jian Li4.   

Abstract

Entities:  

Year:  2021        PMID: 33432745      PMCID: PMC7801855          DOI: 10.1002/wps.20829

Source DB:  PubMed          Journal:  World Psychiatry        ISSN: 1723-8617            Impact factor:   49.548


× No keyword cloud information.
The COVID‐19 pandemic is profoundly impacting mental health worldwide1, 2, 3. Wuhan, China has been the first city to experience the emergency of COVID‐19 and its high hospitalization and casualty rates, as well as the mandatory curfews that were strictly enforced for infection control, with their significant mental health implications . Although a large number of hospitalized COVID‐19 patients recovered and met the clinical criteria for discharge, we hypothesized that mental health problems would occur as major sequelae among COVID‐19 survivors. A total of 4,328 hospitalized COVID‐19 patients who met relevant clinical criteria were discharged between January 18 and March 29, 2020 from five hospitals in Wuhan, China (Wuhan No.1 Hospital, Wuhan Wuchang Hospital, Hubei Provincial Hospital of Traditional Chinese Medicine, Hubei Provincial Hospital of Integrated Chinese and Western Medicine, and Wuhan Pulmonary Hospital). All these COVID‐19 survivors (median age: 59 years, interquartile range, IQR: 47‐68 years; 54.1% female) were followed up and assessed by mental health care specialists. The evaluation period started on the date of hospital discharge and continued through July 28, 2020. Among the survivors, 156 (3.6%) dropped out at some point of the follow‐up. The validated Chinese versions of the Patient Health Questionnaire‐9 (PHQ‐9) and the Generalized Anxiety Disorder‐7 (GAD‐7) were administered to evaluate post‐discharge depression and anxiety. As a reference group, 1,500 randomly selected individuals from the general population of Hubei province were assessed using the same instruments during the same time frame. Chi‐square tests were used to compare the prevalence of mild‐to‐severe mental health problems in the two samples. Among COVID‐19 survivors with depression or anxiety, logistic regression analysis was applied to test whether several variables (including age, gender, education, income level, comorbid chronic physical diseases, and retesting positive for SARS‐CoV‐2) influenced the severity of the mental health condition. The study was approved by the institutional ethics board of Tongji Medical College, Huazhong University of Science and Technology. All participants provided their informed consent. The median duration of the follow‐up period was 144.0 days (IQR: 135‐157). During this period, 615 COVID‐19 survivors (14.2%) were found to have clinically defined depression (i.e., a score of at least 5 on the PHQ‐9) and 528 (12.2%) to have clinically defined anxiety (i.e., a score of at least 5 on the GAD‐7). Four survivors attempted suicide. Compared to the reference group, the risk of both depression and anxiety in COVID‐19 survivors was significantly higher (relative risk, RR=1.2, 95% CI: 1.1‐1.4, p=0.002; and RR=1.4, 95% CI: 1.2‐1.7, p=0.001, respectively). Among the 615 survivors with depression, the risk for a severe condition (i.e., a score of at least 10 on the PHQ‐9) was significantly higher in individuals living alone (odds ratio, OR=5.2, 95% CI: 3.6‐7.1, p<0.001), in females (OR=3.4, 95% CI: 2.8‐5.3, p<0.001), in those with a low income level (OR=2.4, 95% CI: 1.8‐3.5, p=0.012), in those with a comorbid chronic physical disease (OR=2.8, 95% CI: 2.1‐3.7, p=0.032), and in those who retested positive for SARS‐CoV‐2 (OR=10.4, 95% CI: 8.3‐12.5, p<0.001). Age did not significantly influence the severity of depression. Among the 528 COVID‐19 survivors with anxiety, the risk for a severe condition (i.e., a score of at least 10 on the GAD‐7) was significantly higher in individuals with a low educational level (OR=3.5, 95% CI: 3.1‐4.2, p<0.001), in unmarried subjects (OR=1.7, 95% CI: 1.2‐2.8, p=0.025), and in those who retested positive for SARS‐CoV‐2 (OR=4.7, 95% CI: 3.7‐5.8, p<0.001). Age, gender and other social status indices did not influence the severity of anxiety. All the four COVID‐19 survivors who attempted suicide were elderly, had retested positive for SARS‐CoV‐2, and had experienced severe levels of depression and anxiety. In summary, this follow‐up study documents that mental health problems among COVID‐19 survivors in Wuhan are significantly more common than in the general population of the Hubei province. Risk factors for more severe mental health problems include retesting positive for SARS‐CoV‐2, living alone, female gender, comorbid chronic physical diseases, and low education and income levels. Clinicians and policy makers should be aware of the risk of mental health sequelae in COVID‐19 survivors and implement appropriate preventive and treatment measures.
  7 in total

1.  Adaptation of evidence-based suicide prevention strategies during and after the COVID-19 pandemic.

Authors:  Danuta Wasserman; Miriam Iosue; Anika Wuestefeld; Vladimir Carli
Journal:  World Psychiatry       Date:  2020-10       Impact factor: 49.548

2.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

3.  Addressing mental health needs: an integral part of COVID-19 response.

Authors:  Tedros Adhanom Ghebreyesus
Journal:  World Psychiatry       Date:  2020-06       Impact factor: 49.548

4.  A brief measure for assessing generalized anxiety disorder: the GAD-7.

Authors:  Robert L Spitzer; Kurt Kroenke; Janet B W Williams; Bernd Löwe
Journal:  Arch Intern Med       Date:  2006-05-22

5.  Anxiety and depression among general population in China at the peak of the COVID-19 epidemic.

Authors:  Junfeng Li; Zhiyun Yang; Hui Qiu; Yu Wang; Lingyu Jian; Junjun Ji; Kefeng Li
Journal:  World Psychiatry       Date:  2020-06       Impact factor: 49.548

6.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

7.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

  7 in total
  7 in total

1.  The Moderating Effect of Resilience on Mental Health Deterioration among COVID-19 Survivors in a Mexican Sample.

Authors:  Héctor Raúl Pérez-Gómez; Esteban González-Díaz; Marta Herrero; Fabiola de Santos-Ávila; José Luis Vázquez-Castellanos; Pedro Juárez-Rodríguez; Bernardo Moreno-Jiménez; Rosa Martha Meda-Lara
Journal:  Healthcare (Basel)       Date:  2022-02-05

2.  Delirium and Psychiatric Sequelae Associated to SARS-CoV-2 in Asymptomatic Patients With Psychiatric History and Mild Cognitive Impairment as Risk Factors: Three Case Reports.

Authors:  Michele Fabrazzo; Antonio Russo; Mario Luciano; Alessio Camerlengo; Pierluigi Catapano; Bianca Amoroso; Francesco Catapano; Nicola Coppola
Journal:  Front Psychiatry       Date:  2022-04-07       Impact factor: 5.435

3.  Perceived Symptoms, Mental Health and Quality of Life after Hospitalization in COVID-19 Patients.

Authors:  Evangelos C Fradelos; Stylianos Boutlas; Eleni Tsimitrea; Alexandra Sistou; Konstantinos Tourlakopoulos; Ioanna V Papathanasiou; Konstantinos I Gourgoulianis
Journal:  J Pers Med       Date:  2022-04-30

4.  NICLOSAMIDE-EXFOLIATED ANIONIC CLAY NANOHYBRID REPURPOSED AS AN ANTIVIRAL DRUG FOR TACKLING COVID-19; ORAL FORMULATION WITH TWEEN 60/EUDRAGIT S100.

Authors:  N Sanoj Rejinold; Huiyan Piao; Goeun Choi; Geun-Woo Jin; Jin-Ho Choy
Journal:  Clays Clay Miner       Date:  2021-11-11       Impact factor: 2.207

5.  COVID-19-Related Social Isolation Predispose to Problematic Internet and Online Video Gaming Use in Italy.

Authors:  Umberto Volpe; Laura Orsolini; Virginio Salvi; Umberto Albert; Claudia Carmassi; Giuseppe Carrà; Francesca Cirulli; Bernardo Dell'Osso; Mario Luciano; Giulia Menculini; Maria Giulia Nanni; Maurizio Pompili; Gabriele Sani; Gaia Sampogna; Working Group; Andrea Fiorillo
Journal:  Int J Environ Res Public Health       Date:  2022-01-29       Impact factor: 3.390

Review 6.  Post-acute COVID-19 syndrome.

Authors:  David Montani; Laurent Savale; Nicolas Noel; Olivier Meyrignac; Romain Colle; Matthieu Gasnier; Emmanuelle Corruble; Antoine Beurnier; Etienne-Marie Jutant; Tài Pham; Anne-Lise Lecoq; Jean-François Papon; Samy Figueiredo; Anatole Harrois; Marc Humbert; Xavier Monnet
Journal:  Eur Respir Rev       Date:  2022-03-09

7.  Post-COVID-19 mental health and its associated factors at 3-months after discharge: A case-control study.

Authors:  Asmaa Azizi; Doha Achak; Elmadani Saad; Abderraouf Hilali; Ibtissam Youlyouz-Marfak; Abdelghafour Marfak
Journal:  Clin Epidemiol Glob Health       Date:  2022-09-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.